HR 3808 United States House · 117th Congress

Medicare IVIG Access Enhancement Act

Summary

Medicare IVIG Access Enhancement Act This bill requires the Centers for Medicare & Medicaid Services to establish a five-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.

Bill status in committee 1 of 4 stages cleared

Introduction

Jun 2021

Committee Review

Floor Vote

President

Introduced Jun 11, 2021 Last action Jun 14, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 14, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jun 11, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jun 11, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jun 11, 2021

Introduced

Introduced in House

lower

1 primary · 15 co-sponsors

Sponsors

Role

Legislator

Party

State

District

Jenniffer González-Colón

RRepublican

At-Large